ctcbio is IFF(Danisco)'s Verified Partner, and a global probiotics company that has established an extensive network with the world's leading probiotic companies. ctcbio's nutraceutical division has made significant contributions to ctcbio’s growth into the global company it is today, through dedicating over 30 years of hard work to develop probiotic strains with various efficacies and manufacture technologies for stable probiotics, including freeze-drying stabilization technology. Some examples would be pharmaceutical drug stabilization through dual coating using fluidized-bed microencapsulation, pharmaceutical DDS technology and over more than 100 clinical trials.

At ctcbio’s CMRI (CTC Microbiome Research Institute) we are all about probiotics.

At our CMRI we predict stability of individual probiotic strains using CMRI’s Algorithm technology and determine the mixing ratio of mixed probiotic blends using CMRI’s Metagenome technology. We also develop strains that increase stability and efficacy through CMRI’s microbiome analysis technology and conduct qualitative and quantitative analysis of finished products using CMRI’s NGS technology.